<DOC>
	<DOCNO>NCT02327871</DOCNO>
	<brief_summary>To control patient 's body temperature remain major importance especially cardiac arrest ( CA ) . Therapeutic hypothermia ( TH ) target 32-34°C recommended unconscious CA patient . However , available modality induce TH number technical ( side effect ) , logistical ( difficulty placement ) , financial ( cost ) barrier . The Esophageal Cooling Device ( ECD ) multi-chambered silicone heat exchanger place esophagus provide highly efficient heat transfer patient . The ECD device potentially improve effectiveness TH minimize risk exist method ( invasive cooling ) . Initial mathematical animal study show strong support efficacy safety ECD . Placement naso-gastric probe systematic standard care unconscious patient suffer CA . The present study replace usual naso-gastric probe ECD use gastric suction usually do patient . The aim prospective , interventional study assess feasibility safety ECD resuscitate CA-patients treat 32-34°C targeted TH . The primary outcome feasibility inducing , maintain , rewarming patient TH use ECD ( cool rate , rewarming rate , percent time within goal temperature goal-temperature maintenance period ) . Evaluation adverse event ( include cardiac arrhythmia , severe bradycardia , myocardial infarction/re-infarction , dysphagia , odynophagia , aspiration pneumonia , non-aspiration pneumonia , esophageal reflux injury , esophagitis ) closely monitored whole period target temperature management ( secondary endpoint ) .</brief_summary>
	<brief_title>Esophageal Temperature Management After Cardiac Arrest</brief_title>
	<detailed_description>Background The ability control patient 's body temperature wide variety condition extremely important , particular importance CA . TH target 32-34°C targeted temperature management ( TTM ) demonstrably improve outcome least two clinical condition : adult resuscitate CA neonate suffer hypoxic ischemic encephalopathy.1-7 TH recommend CA patient major organization provide resuscitation guideline , include American Heart Association , European Resuscitation Council , International Liaison Committee Resuscitation.8-10 This indication confirm non-expert jury provide clinical recommendation five professional international critical care society ( American Thoracic Society , European Respiratory Society , European Society Intensive Care Medicine , Society Critical Care Medicine , Société de Réanimation de Langue Française ) : jury strongly recommend TTM target 32-34°C preferred treatment ( vs. unstructured temperature management ) out-of-hospital adult CA victim first register electrocardiography rhythm ventricular fibrillation pulseless ventricular tachycardia still unconscious restoration spontaneous circulation.11 Additional evidence exists , albeit low level , use TH comatose survivor CA initially associate non-shockable rhythms.8-10 The debate regard optimal level TTM recently evaluate large randomize controlled trial compare 2 different level TTM perform 28 hours.12 In study similar result regard neuroprotection survival obtain use either 36°C target 33°C target ( i.e . `` real '' TH ) .13 Consequently 2 different level TTM use recently recall expert field . These treatment start soon possible , especially within first 4 hour CA . However delay could prolong 6 10 hour CA.8-11 To date , however , available modality induce precise TTM TH number technical , logistical , financial barrier , include difficulty placement , risk use ( needle stick , infection , blood clot , skin damage ) , high cost . The Esophageal Cooling Device ( ECD ) disposable device potentially improve effectiveness 32-34°C target TH minimize risk exist method invasive methods.14 The ECD multichambered silicone heat exchanger place esophagus provide highly efficient heat transfer patient simultaneously maintain access stomach allow gastric suctioning , decompression , drainage , usually perform patient hospitalized ICUs . The esophagus close proximity blood flow heart great vessel , ECD design take advantage heat exchange environment . The ECD 's ability decompress stomach avoid distention esophagus away device ensures good contact esophageal mucosa , thus maximize heat transfer patient . The ECD replaces standard gastric tube place target patient population routine standard care , make standard medical-grade silicone , generally similar size shape gastric tube currently use . Initial mathematical animal study show strong support efficacy safety ECD.14-16 Study design : Prospective , interventional study evaluate feasibility ( efficacy ) safety ECD patient resuscitate CA treat TH . Patient population : Patient population consist patient suffer resuscitated out-of-hospital in-hospital CA stable return spontaneous circulation ( ROSC ) hemodynamic condition indication TH implementation accord standard recommendation . Data collection : All clinical biological parameter record accord Utstein-style recommendation report resuscitation outcome . Neurologic outcome assess accord Cerebral Performance Category ( CPC ) score . Initial temperature measure via tympanic naso-pharyngeal temperature sensor prehospital field inhospital cath-lab respectively . Continuous temperature measurement ( specifically cool , maintenance , rewarming ) measure bladder temperature sensor , arterial temperature monitoring ( Picco® ) available . Time ECD placement potential side effect record . Specific treatment : The placement ECD follow standard recommendation per Instructions Use . The ECD connect Gaymar console ( Meditherm III , Gamida , France ) . In institution , TH perform patient resuscitate OHCA except present exclusion criterion . TH initiate soon possible administration cold saline 4°C necessary follow application available cooling device ( blanket , endovascular method , etc ) aim target temperature 32-34°C 24 hour recommend . 8-11,13 For enrolled patient , ECD hereby replace cool device usually use ICU . Other treatment : Standard treatment resuscitation CA follow local , national , international guideline previously describe . Briefly , core temperature usually measure use esophageal urinary Foley catheter thermistor probe ( Tyco Healthcare , France ) and/or arterial temperature monitoring ( PiCCO , Pulsion Medical System , France ) available and/or necessary . During TH , sedation perform continuous infusion midazolam propofol sufentanil . Neuromuscular blockade induce use cisatracurium favor cool prevent shiver necessary . Circulatory function monitor radial femoral arterial catheter necessary blood pressure maintain ≥90mmHg systolic &gt; 65mmHg mean arterial pressure . Hypotension treat dobutamine norepinephrine epinephrine titrate target blood pressure accord cardiac output monitor use echocardiogram , PiCCO® system accord physician charge . Fluid management leave discretion attend physician . Neuromonitoring prognostication CA use serial clinical examination , biomarkers ( lactate , creatinine , NSE , S100B protein ) , transcranial Doppler , daily Electro-Encephalo-Gram , cerebral CT-scan MRI , Somato-Sensory-Evoked-Potential necessary . Statistical analysis : Since pilot study sample size 15 patient calculate base local feasibility consideration . This non comparative study . Thus statistical analysis descriptive . For quantitative parameter , mean , SD , median quartile calculate . For qualitative parameter , percentage two-sided 95 % confidence interval calculate . All analysis make patient received ECD . In case unsuccessful attempt use ECD , patient list . Informed consent ethical consideration : This study conduct accord principle Declaration Helsinki World Medical Association . The protocol submit , modify accept local Ethics Committee local AP-HP institution ( Institutional Review Board Paris VI Hospital , Comité de Protection de Personnes de GHPS , Paris 12ème , approval CPP/79-14 , ID RCB 2014-A01145-42 , 10/28/2014 ) . Written inform consent obtain inclusion patient 's next kin present patient 's admission.. According French law local Ethics Committee short delay enroll patient , family member reach inclusion despite systematic research perform physician charge patient soon patient 's admission , patient present inclusion criterion exclusion criterion include emergency . In case , survive patient without severe neurological sequel give write informed consent soon possible ( i.e . awake ) . An approval regard use ECD French committee responsible device use human being ( Agence Nationale de Sécurité du Médicament et de produits de santé , N° DMDTP/DMTECH/KB/2014-A01145-42 , 9/4/2014 ) CE mark ( N° , 03/24/2014 ) specifically obtain separately . Specific insurance deliver ACT society French represent company IST Cardiology ( Chubb Insurance Company Europe SE , 10/10/2014 , protocol 2014-A01145-42 ) . This trial also declare French Informatics ' Society ( Commission Nationale Informatique et Liberté N°1593420 ) . References : 1 . HACA . Mild therapeutic hypothermia improve neurologic outcome cardiac arrest . N Engl J Med . 2002 ; 346 ( 8 ) :549-556 . 2 . Bernard SA , Gray TW , Buist MD , Jones BM , Silvester W , Gutteridge G , et al . Treatment comatose survivor out-of-hospital cardiac arrest induce hypothermia . N Engl J Med . Feb 21 2002 ; 346 ( 8 ) :557-563 . 3 . Shankaran S , Laptook AR , Poole WK . Hypothermia perinatal asphyxial encephalopathy . N Engl J Med . Mar 18 2010 ; 362 ( 11 ) :1051-1052 ; author reply 1052 . 4 . Sinclair HL , Andrews PJ . Bench-to-bedside review : Hypothermia traumatic brain injury . Crit Care . Feb 15 2010 ; 14 ( 1 ) :204 . 5 . Froehler MT , Ovbiagele B . Therapeutic hypothermia acute ischemic stroke . Expert Rev Cardiovasc Ther . Apr 2010 ; 8 ( 4 ) :593-603 . 6 . Dietrich WD , Bramlett HM . The Evidence Hypothermia Neuroprotectant Traumatic Brain Injury . Neurotherapeutics : The Journal American Society Experimental NeuroTherapeutics . 2010 ; 7 ( 1 ) :43-50 . 7 . Kelly FE , Nolan JP . The effect mild induced hypothermia myocardium : systematic review . Anaesthesia . May 2010 ; 65 ( 5 ) :505-515 . 8 . Peberdy MA , Callaway CW , Neumar RW , Geocadin RG , Zimmerman JL , Donnino M , et al . Part 9 : post-cardiac arrest care : 2010 American Heart Association Guidelines Cardiopulmonary Resuscitation Emergency Cardiovascular Care . Circulation . Nov 2 2010 ; 122 ( 18 Suppl 3 ) : S768-786 . 9 . Nolan JP , Neumar RW , Adrie C , Aibiki M , Berg RA , Bottiger BW , et al . Post-cardiac arrest syndrome : Epidemiology , pathophysiology , treatment , prognostication A Scientific Statement International Liaison Committee Resuscitation ; American Heart Association Emergency Cardiovascular Care Committee ; Council Cardiovascular Surgery Anesthesia ; Council Cardiopulmonary , Perioperative , Critical Care ; Council Clinical Cardiology ; Council Stroke . Resuscitation . 2008 ; 79 ( 3 ) :350-379 . 10 . Nolan JP , Morley PT , Hoek TL , Hickey RW . Therapeutic hypothermia cardiac arrest . An advisory statement Advancement Life support Task Force International Liaison committee Resuscitation . Resuscitation . 2003 ; 57 ( 3 ) :231-235 . 11 . Nunnally ME , Jaeschke R , Bellingan GJ , Lacroix J , Mourvillier B , Rodriguez-Vega GM , et al . Targeted temperature management critical care : A report recommendation five professional society . Crit Care Med . Dec 23 2010 . 12 . Nielsen N , Wetterslev J , Cronberg T , et al . Targeted Temperature Management 33 degree C versus 36 degree C Cardiac Arrest . N Engl J Med . 2013 ; 369:2197-2206 . 13 . ILCOR statement Nielsen study publish N Engl J Med . http : //www.med.upenn.edu/resuscitation/documents/TTMILCOR.pdf 14 . Kulstad E , Metzger AK , Courtney DM , Rees J , Shanley P , Matsuura T , et al . Induction , maintenance , reversal therapeutic hypothermia esophageal heat transfer device . Resuscitation . Jul 1 2013 . 15 . Kulstad EB , Courtney DM , Waller D. Induction therapeutic hypothermia via esophagus : proof concept study . World J Emerg Med . 2012 ; 3 ( 2 ) :118-122 . 16 . Vaicys V , Eason A , Schieber JD , Kulstad EB . Therapeutic hypothermia induction via esophageal route-a computer simulation . Am J Emerg Med . Jul 2012 ; 30 ( 6 ) :932-935 .</detailed_description>
	<mesh_term>Heart Arrest</mesh_term>
	<criteria>Adult patient ( age 18 year ) Successfully resuscitate outofhospital CA With sustained ROSC ( ROSC maintain &gt; 20/minutes ) Admitted ICU Comatose ( obey verbal command ) And treat TH target 3234°C Patient &lt; 18 y.o . Patients know esophageal deformity , evidence esophageal trauma , previous esophageal disease ( example , know esophageal varix , cirrhosis , history esophagectomy , previous swallow disorder dysphagia , achalasia , know ingestion acidic caustic poison within prior 24 hour etc. ) . Patients less 40 kg body mass . Female patient know pregnant . Terminal disease `` resuscitate order '' could lead earlyonset therapeutic withdrawal ( &lt; 48 hour collapse ) . Unstable ROSC ( define impossibility maintain ROSC palpable pulse &gt; 20/minutes ) , unstable hemodynamic condition ( define intractable severe cardiogenic shock ECLS require ) could lead multiorgan failure earlyonset death ( &lt; 48 hour collapse ) . Accidental hypothermia hypothermia &lt; 30°C admission Prolonged delay CA ROSC ( i.e . time ROSC &gt; 60min ) Prolonged delay ROSC inclusion &gt; 360min Conscious patient ( obey verbal command start TH ) Severe bleed diathesis uncontrolled hemorrhage inclusion Esophageal bleed ECD insertion Preexisting severe conductive disorder require pacing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Therapeutic hypothermia</keyword>
	<keyword>patient</keyword>
	<keyword>Safety , Efficacy</keyword>
</DOC>